The safety and immunogenicity of a two-dose schedule of CoronaVac, and the immune persistence of vaccination for six months, in people living with HIV: A multicenter prospective cohort study

BACKGROUND: People living with HIV (PLWH) are more vulnerable to SARS-CoV-2. However, evidence on the immunogenicity of coronavirus disease 2019 (COVID-19) vaccines in this population is insufficient. The objective of this study is to assess the immunogenicity and safety of the two-dose schedule of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuxiao, Qiao, Ying, Huo, Yuqi, Wang, Li, Liang, Shijie, Yu, Maohe, Lan, Xinquan, Song, Moxin, Zhang, Xiangjun, Yan, Ying, Xu, Junjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040764/
https://www.ncbi.nlm.nih.gov/pubmed/36993947
http://dx.doi.org/10.3389/fimmu.2023.1129651

Ejemplares similares

Ejemplares similares